Valneva shares fall as French health body advises against its COVID-19 vaccine

Valneva logo and stock graph are seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration

PARIS, Dec 8 (Reuters) - Shares in France's Valneva (VLS.PA) reversed course on the Paris stock market and traded down by around 2.8% after the country's public health authority said it would advise the government not to use the company's COVID-19 vaccine for its vaccination strategy.

Reporting by Tassilo Hummel; Editing by Sudip Kar-Gupta

Our Standards: The Thomson Reuters Trust Principles.